Skip Navigation


European Heart Journal Advance Access originally published online on April 16, 2008
European Heart Journal 2008 29(10):1335-1336; doi:10.1093/eurheartj/ehn150
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
29/10/1335-a    most recent
ehn150v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Smulders, Y.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Smulders, Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

New cardiovascular risk determinants do exist and are clinically useful: reply

Yvo Smulders

UV University Medical Center
Internal Medicine
PO Box 7057
Amsterdam 1007MB
The Netherlands
Tel: +31 20 44 44 307
Fax: +31 20 44 44 313
Email: y.smulders@vumc.nl

The first 10% of the full text of this article appears below.

Dr Levinson remarks that the clinical value of biomarkers can only be defined in studies showing improved outcome after incorporation of these biomarkers in risk models. We agree that this formally provides the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?